drugset / Trial / NCT04356859

The Acute Burn ResUscitation Multicenter Prospective Trial

NCT04356859

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone), in adults with an acute burn involving at least 25% of their total body surface area.

Timeline

Start
2021-04-22
Primary completion
2025-09-29
Completion
2025-09-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 5 %

Indications

No indication recorded.